Molecular Pathways Controlling Ovarian Gene Expression
控制卵巢基因表达的分子途径
基本信息
- 批准号:8431437
- 负责人:
- 金额:$ 27.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-02-01 至 2015-01-31
- 项目状态:已结题
- 来源:
- 关键词:AchievementActivinsAddressAdenovirusesAllelesAndrogensAnimalsApoptosisApoptoticAromataseBiological AssayCYP17A1 geneCell Culture TechniquesCell Cycle ProgressionCell DeathCell ProliferationCell SurvivalCell physiologyCellsChIP-on-chipCodeDNADefectDevelopmentEmbryoEnzymesEstradiolEstrogensEtiologyFemaleFertilityGene ExpressionGene Expression RegulationGene TargetingGenesGenetic RecombinationGenomicsGranulosa-Lutein CellsGrowthHealthHormonesIn VitroInfectionInfertilityInvestigationKnockout MiceKnowledgeLightMicroarray AnalysisMolecularMusOvarianOvarian CyclesOvarian DiseasesOvarian Granulosa CellOvaryPaperPathway interactionsPhysiologicalPlayProductionPublishingReproductionReproductive ProcessRoleStagingSteroid biosynthesisSteroidsStructureTechnologyTestingdesignfolliculogenesisgene repressiongranulosa cellgranulosa cell tumorimproved functioningin vivomutantoverexpressionpromoterrecombinaseresponsetheca celltranscription factor
项目摘要
DESCRIPTION (provided by applicant): Coordinated activation and repression of genes are essential for the normal progress of the ovarian cycle. Ovarian granulosa cells express high levels of the transcription factors GATA-4 and GATA-6. In cell cultures, these transcription factors were shown to play key roles in the expression of enzymes involved in steroidogenesis. We have demonstrated in several recently published papers that GATA-4 is critical for the production of estradiol, which is essential for granulosa cell proliferation and follicle maturation. In addition, the finding that low expression of GATA-4 is associated with follicular cell death suggests that this factor also plays a survival role in the ovary. Because GATA-4 and GATA-6 null mice are embryonic lethal, the ultimate role of GATA in ovarian function remains unknown. This study is therefore designed to determine the physiological role of GATA-4 and GATA-6 in ovarian steroidogenesis, follicular development, and female fertility. The specific aims of this study are: 1- To generate ovarian-specific GATA-4 and GATA-6 null mice in order to find out the explicit roles of these transcription factors in the ovary in vivo. The Cre-lox technology will be used to delete part of the coding region of GATA-4, GATA-6, or their combination. We expect these mice to have severe defects in steroid production and in follicular development. 2- To determine the effect of GATA-4 and GATA-6 deletion on ovarian cells in vitro. Granulosa cells lacking GATA-4, GATA-6, or both will be used to examine the specific roles of these factors in steroidogenesis, cell proliferation, granulosa-cell hormone response, and gene expression. 3- To identify those genes that are regulated by GATA-4 and GATA-6 in fully functional ovaries in vivo, we will use ChIP-on-chip assays. All the results obtained to date indicate that GATA-4 and GATA-6 may play a crucial role in the normal function of the ovary. We expect from this investigation to clearly define the function of GATA-4 and GATA-6 in the steroidogenic capacity and growth of granulosa cells, to determine whether GATA-4 and GATA-6 have redundant effects on these cells, and to identify GATA-4 and GATA-6 target genes in the ovary. This study will not only provide critically important information on the regulatory mechanism underlying normal ovarian function but also may shed light on ovarian diseases due to improper granulosa cell function such as granulosa cell tumors and infertility.
描述(由申请人提供):基因的协调激活和抑制对于卵巢周期的正常进展至关重要。卵巢颗粒细胞表达高水平的转录因子 GATA-4 和 GATA-6。在细胞培养物中,这些转录因子在类固醇生成相关酶的表达中发挥着关键作用。我们在最近发表的几篇论文中证明,GATA-4 对于雌二醇的产生至关重要,而雌二醇对于颗粒细胞增殖和卵泡成熟至关重要。此外,GATA-4低表达与卵泡细胞死亡相关的发现表明该因子也在卵巢中发挥着生存作用。由于 GATA-4 和 GATA-6 缺失小鼠是胚胎致死的,因此 GATA 在卵巢功能中的最终作用仍不清楚。因此,本研究旨在确定 GATA-4 和 GATA-6 在卵巢类固醇生成、卵泡发育和女性生育能力中的生理作用。本研究的具体目的是: 1- 产生卵巢特异性GATA-4和GATA-6无效小鼠,以找出这些转录因子在体内卵巢中的明确作用。 Cre-lox技术将用于删除GATA-4、GATA-6或其组合的部分编码区。我们预计这些小鼠在类固醇产生和卵泡发育方面存在严重缺陷。 2-确定GATA-4和GATA-6缺失对体外卵巢细胞的影响。缺乏 GATA-4、GATA-6 或两者的颗粒细胞将用于检查这些因子在类固醇生成、细胞增殖、颗粒细胞激素反应和基因表达中的具体作用。 3- 为了识别体内功能齐全的卵巢中受 GATA-4 和 GATA-6 调节的基因,我们将使用 ChIP 芯片检测。迄今为止获得的所有结果表明GATA-4和GATA-6可能在卵巢的正常功能中发挥着至关重要的作用。我们希望通过这项研究清楚地定义 GATA-4 和 GATA-6 在类固醇生成能力和颗粒细胞生长中的功能,确定 GATA-4 和 GATA-6 是否对这些细胞有多余的影响,并确定 GATA- 4 和 GATA-6 卵巢中的靶基因。这项研究不仅将提供关于正常卵巢功能的调节机制的极其重要的信息,而且还可能揭示由于颗粒细胞功能不当引起的卵巢疾病,例如颗粒细胞瘤和不孕症。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The long and short of the prolactin receptor: the corpus luteum needs them both!
催乳素受体的长和短:黄体都需要它们!
- DOI:
- 发表时间:2012-03
- 期刊:
- 影响因子:3.6
- 作者:Stocco; Carlos
- 通讯作者:Carlos
GATA Regulation and Function During the Ovarian Life Cycle.
卵巢生命周期中的 GATA 调节和功能。
- DOI:10.1016/bs.vh.2018.01.014
- 发表时间:2024-09-13
- 期刊:
- 影响因子:0
- 作者:J. Bennett;C. Stocco
- 通讯作者:C. Stocco
Regulation of AMH by oocyte-specific growth factors in human primary cumulus cells.
人原代卵丘细胞中卵母细胞特异性生长因子对 AMH 的调节。
- DOI:10.1530/rep-17-0421
- 发表时间:2017-12
- 期刊:
- 影响因子:3.8
- 作者:Convissar S;Armouti M;Fierro MA;Winston NJ;Scoccia H;Zamah AM;Stocco C
- 通讯作者:Stocco C
Testosterone, not 5ýý-dihydrotestosterone, stimulates LRH-1 leading to FSH-independent expression of Cyp19 and P450scc in granulosa cells.
睾酮(而非 5××-二氢睾酮)刺激 LRH-1,导致颗粒细胞中 Cyp19 和 P450scc 的 FSH 独立表达。
- DOI:
- 发表时间:2011-04
- 期刊:
- 影响因子:0
- 作者:Wu, Yan;Bennett, Jill;Talla, Deepika;Stocco, Carlos
- 通讯作者:Stocco, Carlos
Tissue physiology and pathology of aromatase.
芳香酶的组织生理学和病理学。
- DOI:
- 发表时间:2012-01
- 期刊:
- 影响因子:2.7
- 作者:Stocco; Carlos
- 通讯作者:Carlos
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CARLOS OSCAR STOCCO其他文献
CARLOS OSCAR STOCCO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CARLOS OSCAR STOCCO', 18)}}的其他基金
Salt-Inducible Kinase Regulation of Ovarian Granulosa Cells
卵巢颗粒细胞的盐诱导激酶调节
- 批准号:
10643707 - 财政年份:2019
- 资助金额:
$ 27.4万 - 项目类别:
Salt-Inducible Kinase Regulation of Ovarian Granulosa Cells
卵巢颗粒细胞的盐诱导激酶调节
- 批准号:
10406988 - 财政年份:2019
- 资助金额:
$ 27.4万 - 项目类别:
Salt-Inducible Kinase Regulation of Ovarian Granulosa Cells
卵巢颗粒细胞的盐诱导激酶调节
- 批准号:
10011939 - 财政年份:2019
- 资助金额:
$ 27.4万 - 项目类别:
Salt-Inducible Kinase Regulation of Ovarian Granulosa Cells
卵巢颗粒细胞的盐诱导激酶调节
- 批准号:
10165768 - 财政年份:2019
- 资助金额:
$ 27.4万 - 项目类别:
Regulation of Aromatase Expression in the Corpus Luteum
黄体中芳香酶表达的调节
- 批准号:
8206281 - 财政年份:2011
- 资助金额:
$ 27.4万 - 项目类别:
Regulation of Aromatase Expression in the Corpus Luteum
黄体中芳香酶表达的调节
- 批准号:
8045278 - 财政年份:2011
- 资助金额:
$ 27.4万 - 项目类别:
Molecular Pathways Controlling Ovarian Gene Expression
控制卵巢基因表达的分子途径
- 批准号:
7761207 - 财政年份:2009
- 资助金额:
$ 27.4万 - 项目类别:
Molecular Pathways Controlling Ovarian Gene Expression
控制卵巢基因表达的分子途径
- 批准号:
7913605 - 财政年份:2009
- 资助金额:
$ 27.4万 - 项目类别:
Molecular Pathways Controlling Ovarian Gene Expression
控制卵巢基因表达的分子途径
- 批准号:
8212331 - 财政年份:2009
- 资助金额:
$ 27.4万 - 项目类别:
Molecular Pathways Controlling Ovarian Gene Expression
控制卵巢基因表达的分子途径
- 批准号:
8044047 - 财政年份:2009
- 资助金额:
$ 27.4万 - 项目类别:
相似国自然基金
印度梨形孢激活根系质子泵促进水稻高效利用土壤磷素的调控机制
- 批准号:42307419
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
细胞外基质通过整合素αvβ3调控GSDMD介导的细胞焦亡通路在原始卵泡激活中的作用和机制研究
- 批准号:82301849
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
杜氏藻中虾青素生物合成受阻遏的分子机制及其激活途径研究
- 批准号:32372286
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
产酸拟杆菌通过代谢产物N-乙酰血清素激活IDO1-AhR信号介导Treg-巨噬细胞轴减轻脓毒症肝损伤的作用及机制
- 批准号:82330067
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:重点项目
胰岛素受体胞内激酶活性结构域“激活”/“抑制”构象的解析及功能调节机制
- 批准号:32371227
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Preclinical Development of a Novel Gene Therapeutic for Inclusion Body Myositis
包涵体肌炎新基因疗法的临床前开发
- 批准号:
10709907 - 财政年份:2022
- 资助金额:
$ 27.4万 - 项目类别:
Preclinical Development of a Novel Gene Therapeutic for Inclusion Body Myositis
包涵体肌炎新基因疗法的临床前开发
- 批准号:
10601641 - 财政年份:2022
- 资助金额:
$ 27.4万 - 项目类别:
The Role of Activin-like kinase 5 (ALK5) for maintaining microglia and astrocyte homeostasis and activation
激活素样激酶 5 (ALK5) 在维持小胶质细胞和星形胶质细胞稳态和激活中的作用
- 批准号:
10388033 - 财政年份:2022
- 资助金额:
$ 27.4万 - 项目类别: